February 25, 2021
Business News

Mauna Kea Technologies Reports Fourth Quarter and Full Year 2020 Sales


PARIS & BOSTON–()–Regulatory News:

Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced sales results for the fourth quarter and twelve months of fiscal year 2020.

Fourth Quarter of 2020 Sales Summary

  • Total sales for the fourth quarter of 2020 increased €0.7 million, or 41% year-over-year, to €2.4 million

    • Consumables sales decreased €0.1 million, or 5% year-over-year, to €1.0 million
    • Systems sales increased €0.7 million, or 192% year-over-year, to €1.1 million
    • Services sales decreased 2% year-over-year to €0.3 million

Full Year 2020…



Click here to view the original article.

Related Posts

You might also like ...

PureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Phase 2 Trial Evaluating KarXT in Schizophrenia
Ecoppia Strengthens Its Presence in the Middle East with a first Project in Egypt
Alignment Healthcare Expands Management Team With Three Key Executives